SOURCE: Implant Sciences Corp

August 15, 2011 12:14 ET

U.S. Congressman John Tierney to Visit Implant Sciences

Tour of Growing Homeland Security Equipment Manufacturer to Focus on Creating US Jobs and Homeland Security

WILMINGTON, MA--(Marketwire - Aug 15, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced that on August 17th, U.S. Congressman John F. Tierney will visit the Company's headquarters and manufacturing facilities. Congressman Tierney represents the 6th District of Massachusetts, and is the Ranking Democrat of the House Oversight and Government Reform's Subcommittee on National Security, Homeland Defense and Foreign Operations.

Topics of discussion during the tour will include Congressman Tierney's involvement in increased homeland security, American job growth, export creation, and how the U.S. government can help small businesses in Massachusetts support these goals.

"Small businesses, like Implant Sciences, help maintain a solid foundation for our local economy," Congressman John Tierney said. "Implant Sciences is manufacturing homeland security equipment right here at home and creating jobs for members of our community. I look forward to discussing how Congress' policies have and can support innovation leading to the creation of more jobs by small businesses," Congressman Tierney said.

Implant Sciences has sold more that 1,300 of its Quantum Sniffer™ QS-H150 hand-held explosives trace detector in 27 countries around the world. The Company recently introduced a bench-top explosives and narcotics trace detection device, the QS-B220, which is designed for use in airport checkpoint, air cargo screening, and borders and customs applications.

Glenn D. Bolduc, President and CEO of Implant Sciences, added, "We look forward to Congressman Tierney's visit, and appreciate his leadership and support of our nation's homeland security efforts. This visit is a demonstration of his commitment to securing our nation from terrorist threats and to our economic growth by supporting small businesses. As Implant Sciences grows, we can create a new Massachusetts job for every 45 additional explosives trace detection systems we add to our annual sales volume."

About the Quantum Sniffer QS-H150

The QS-H150 Quantum Sniffer is a hand-held explosive trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.

About the Quantum Sniffer QS-B220

The QS-B220 Quantum Sniffer, introduced in May 2011, is a bench-top explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, or homemade explosives and narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:


    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact